Evidence map›Paper›PMID 39916636›Full record

ArticleThe Journal of dermatology2025

Validation of Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score and establishment of novel score in Japanese patients with necrotizing fasciitis (J-LRINEC score).

Yuta Norimatsu, Takemichi Fukasawa, Yuki Ohno, Yurie Norimatsu, Kazuki M Matsuda, Teruyoshi Hisamoto, Hirohito Kotani, Ai Kuzumi, Asako Yoshizaki-Ogawa, Takuya Miyagawa and 3 more

Abstract readValidation Study
In one paragraph

Article in The Journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Risk factors and predictors of in-hospital mortality in necrotizing fasciitis: a five-year retrospective cohort study from a tertiary care center in Colombia.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuta NorimatsuDepartment of Dermatology, JR Tokyo General Hospital, Japan.ORCID https://orcid.org/0000-0002-7649-0806
Takemichi FukasawaDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Yuki OhnoDepartment of Dermatology, JR Tokyo General Hospital, Japan.
Yurie NorimatsuDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0852-0054
Kazuki M MatsudaDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Teruyoshi HisamotoDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Hirohito KotaniDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Ai KuzumiDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Asako Yoshizaki-OgawaDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Takuya MiyagawaDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Koji ObaDepartment of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shinichi SatoDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Ayumi YoshizakiDepartment of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-8194-9140

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score is widely used to distinguish between necrotizing fasciitis and cellulitis. However, LRINEC scores are not as sensitive or specific as initially reported, possibly due to differences in patient backgrounds in different countries. Here, we examined the validity of LRINEC scores in Japanese patients. We also investigated the possibility of developing a new scoring system. Patients with necrotizing fasciitis (n = 56) and cellulitis (n = 209) were retrospectively evaluated. The data were split into training (n = 199) and validation (n = 66) datasets. A logistic regression analysis was used to calculate the C-statistics of the LRINEC scores. A new equation was formulated using logistic regression analysis with an appropriate variable selection (Laboratory Risk Indicator for Necrotizing Fasciitis for Japanese Patients [J-LRINEC] score). The J-LRINEC score had a C-statistic of 0.9683, sensitivity of 91.4%, and specificity of 84.8%. The LRINEC score had a C-statistic of 0.914 and specificity of 96%; however, its usefulness was limited by its sensitivity of 68.9%. Our results suggest that the LRINEC score is valid for Japanese patients; however, the J-LRINEC score showed higher sensitivity and specificity, suggesting that it may be a useful tool for differentiating cellulitis from necrotizing fasciitis among Japanese patients.

Indexed as

CellulitisFasciitis, NecrotizingAdultAgedAged, 80 and overDiagnosis, DifferentialEast Asian PeopleFemaleHumansJapanMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsSensitivity and SpecificitycellulitisLaboratory Risk Indicator for Necrotizing Fasciitis for Japanese Patients [J‐LRINEC]Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) scorenecrotizing fasciitisphlegmon

Identifiers

PMID39916636
PMCPMC11883723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.